MAP3K1-targeting therapeutic artificial miRNA suppresses the growth and invasion of breast cancer in vivo and in vitro-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MAP3K1-targeting therapeutic artificial miRNA suppresses the growth and invasion of breast cancer in vivo and in vitro

Published:2016-01-04 Issue:1 Volume:5 Page:
ISSN:2193-1801
Container-title:SpringerPlus
language:en
Short-container-title:SpringerPlus

Author:

Liu Chun,Wang Shengjie,Zhu Shunxing,Wang Haifeng,Gu Jiayi,Gui Zeping,Jing Jin,Hou Xiaofan,Shao Yixiang

Funder

Natural Science Foundation of the Jiangsu Higher Education Institutions

Doctoral scientific research foundation of Nantong University

Natural science foundation of Nantong University

College student’s innovation training program of Nantong University

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://link.springer.com/content/pdf/10.1186/s40064-015-1597-z.pdf

Reference38 articles.

1. Bian D, Su S, Mahanivong C, Cheng RK, Han Q, Pan ZK et al (2004) Lysophosphatidic Acid Stimulates Ovarian Cancer Cell Migration via a Ras-MEK Kinase 1 Pathway. Cancer Res 64(12):4209–4217

2. Bianchi-Smiraglia A, Paesante S, Bakin AV (2013) Integrin beta5 contributes to the tumorigenic potential of breast cancer cells through the Src-FAK and MEK-ERK signaling pathways. Oncogene 32(25):3049–3058

3. Biswas DK, Shi Q, Baily S, Strickland I, Ghosh S, Pardee AB et al (2004) NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis. Proc Natl Acad Sci USA 101(27):10137–10142

4. Chen L, Mayer JA, Krisko TI, Speers CW, Wang T, Hilsenbeck SG et al (2009) Inhibition of the p38 kinase suppresses the proliferation of human ER-negative breast cancer cells. Cancer Res 69(23):8853–8861

5. Cocolakis E, Lemay S, Ali S, Lebrun JJ (2001) The p38 MAPK pathway is required for cell growth inhibition of human breast cancer cells in response to activin. J Biol Chem 276(21):18430–18436

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effect of MiR320a on Lung Cancer;MicroRNA;2024-11

2. Role of Non-coding RNAs in the Response of Glioblastoma to Temozolomide;Molecular Neurobiology;2024-07-18

3. Nanotechnology for the theranostic opportunity of breast cancer lung metastasis: recent advancements and future challenges;Frontiers in Bioengineering and Biotechnology;2024-05-31

4. MAP3K1 Identified as a Prognostic Biomarker in Breast Cancer After Multi-omics Bioinformatics Analysis;2023-12-20

5. The combined signatures of telomere and immune cell landscape provide a prognostic and therapeutic biomarker in glioma;Frontiers in Immunology;2023-08-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3